Want to see BHILQ full AI Analyst Report?
Benson Hill (BHILQ) AI Stock Analysis
Top Page
Benson Hill
(Other OTC:BHILQ)
Benson Hill's stock score reflects significant financial challenges, including declining revenues and high leverage, which are the primary concerns. The technical analysis does not show signs of recovery, and the negative valuation metrics further contribute to the low score. Improvements in cash flow management are noted but are insufficient to offset the broader financial instability.
Benson Hill (BHILQ) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $611
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- 0.0
- Beta (1Y)
- -24829.19
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- US
- Employees
- 270
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Agricultural Inputs
Benson Hill Business Overview & Revenue Model
Company Description
Benson Hill, Inc., including its subsidiaries, operates as an innovative food technology company focused on leveraging the natural genetic variation within plants. The organization's activities are divided into two main areas: Ingredients and Fresh....
How the Company Makes Money
Benson Hill generates revenue primarily through its proprietary CropOS platform and its associated plant breeding and biotechnology services. The company earns money by developing and licensing improved crop varieties, which are designed to enhance y...
Benson Hill Earnings Call Summary
The earnings call presented significant achievements such as revenue growth, debt reduction, and cost-cutting success, positioning the company for future opportunities. However, challenges remain with goodwill impairment, expected revenue decline in 2024 due to asset divestitures, and concerns over cash burn. The company is in a transition phase, focusing on leveraging its technology and strategic partnerships.
Q4-2023 Updates
Positive Updates
Negative Updates
Company Guidance
During the Benson Hill Q4 2023 earnings call, management provided a comprehensive update on the company's strategic initiatives and financial performance metrics. The company reported consolidated revenues of $473 million for 2023, marking a 24% year-over-year improvement, with proprietary grain products growing by 52% and nonproprietary grain products by 18%. Gross profit reached $23 million, more than tripling the prior year's figure, while adjusted EBITDA showed a loss of $48 million, improved by over 40% from the previous year. The company successfully reduced recurring operating expenses (OpEx) and capital expenditures (CapEx) by more than 33% and ended the year with approximately $49 million in cash. Looking ahead to 2024, Benson Hill aims to transition to an asset-light business model, focusing on strategic partnerships and licensing deals. While revenues are expected to decline due to recent asset divestitures, the company anticipates enhancing earnings quality and reducing cash burn. Key performance areas for 2024 include transitioning from the legacy business model, improving operating margins, securing partnerships, optimizing capital structure, and expanding its intellectual property and technology pipeline.
Benson Hill Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BHILQ, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at is Neutral, neither overbought nor oversold. The STOCH value of is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BHILQ.
Benson Hill Risk Analysis
Benson Hill disclosed 59 risk factors in its most recent earnings report. Benson Hill reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
2 New RisksBenson Hill Peers Comparison
Overall Rating
SEED47Neutral
AVD44Neutral
RKDA39Underperform
BHILQ39Underperform
BIOX34Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 47Neutral | $10.95M | -0.83 | 88.44% | ― | -25.50% | -905.27% | |
| 44Neutral | $32.45M | -0.58 | -27.83% | ― | -3.54% | 56.67% | |
| 39Underperform | $380.41K | -0.02 | -339.85% | ― | -12.24% | 17.56% | |
| 39Underperform | $6 | 0.00 | -82.38% | ― | ― | ― | |
| 34Underperform | $13.15M | -0.06 | -216.09% | ― | -26.10% | 14.85% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| BHILQ | Benson Hill, Inc. | 0.01 | -0.05 | -82.14% | |
| AVD | American Vanguard Corporation | 1.10 | -3.57 | -76.45% | |
| SEED | Origin Agritech | 0.77 | -0.88 | -53.09% | |
| RKDA | Arcadia Biosciences Inc. | 0.16 | -3.45 | -95.65% | |
| BIOX | Bioceres Crop Solutions | 0.21 | -1.65 | -88.82% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Feb 01, 2025